Alexander Zemtsov is a Dermatology physician. OpenAlex indexes 78 publications with 782 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3500 W Purdue Ave
Muncie, IN 473046357
Telephone
765-747-6090Provider last certified this registry record 11 Mar 2021.
Industry payments
32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year20257 payments
- ABBVIE INC.Program year202515 payments
- Kerecis LimitedProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
52.2%Tetracycline-class Drug43.2%Doxycycline Hyclate100%Part D≥284 patientsAzole Antifungal7%Ketoconazole100%Part D≥26 patients+ 1 more class in this area
Dermatology
13.8%Corticosteroid8.9%Triamcinolone Acetonide100%Part D≥52 patientsInterleukin-4 Receptor alpha Antagonist4.9%Dupixent Syringe65%Dupixent Pen35%Part D<11 patientsSensory organs
11.3%Corticosteroid11.3%Clobetasol Propionate51%Hydrocortisone28%Betamethasone Dipropionate21%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Skin ultrasonography and magnetic resonance; new clinical applications and instrumentation
Skin Research and Technology
2024 - Livedo reticularis as an initial clinical manifestation of gemcitabine‐induced hemolytic uremic syndrome
The Journal of Dermatology
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”